NCT04521361CompletedPhase 1
A study to assess how radium-223 moves through the patients with prostate cancer receiving radium-223 dichloride treatment.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Apr 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 51 (actual)
- First submitted
- 8 Jan 2024
- Start date
- 25 Aug 2020
- Lead sponsor
- Bayer Consumer Care AG
- Diseases
- Prostate cancer
- NCT number
- NCT04521361
- EU CT number
- 2023-506435-15-00
- EudraCT number
- 2019-000475-17
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 51
- 8 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH Coordinator of this site? Confirm its status | Salzburg | Austria | Completed |
| Institut Regional Du Cancer De Montpellier Coordinator of this site? Confirm its status | Montpellier Cedex 5 | France | Completed |
| Centre Hospitalier Lyon-Sud Coordinator of this site? Confirm its status | Pierre-Bénite | France | Completed |
| Institut De Cancerologie De L Ouest Coordinator of this site? Confirm its status | St Herblain | France | Completed |
| Institut Universitaire Du Cancer Toulouse-Oncopole Coordinator of this site? Confirm its status | Toulouse Cedex 9 | France | Completed |
| Azienda USL IRCCS di Reggio Emilia Coordinator of this site? Confirm its status | Reggio Emilia | Italy | Completed |
| Nacionalinis Vezio Institutas Coordinator of this site? Confirm its status | Vilnius | Lithuania | Completed |
| Vilniaus universiteto ligonine Santaros klinikos VšĮ Coordinator of this site? Confirm its status | Vilnius | Lithuania | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.